Evangelos Pazarentzos
Impact in
- Cell Biology top 2%
- Hippo pathway signaling and YAP/TAZ
- Endoplasmic Reticulum Stress and Disease
- Cancer Research top 10%
Papers in
-
- NF-κB Signaling Pathways 4
- Cancer, Hypoxia, and Metabolism 3
- Cancer Genomics and Diagnostics 2
-
- Cell death mechanisms and regulation 5
- Mitochondrial Function and Pathology 5
- PI3K/AKT/mTOR signaling in cancer 4
- Co-authors
- Stefan Grimm (8 shared papers)Christoph Datler (7 shared papers)Ryota Iwasawa (2 shared papers)Anne‐Laure Mahul‐Mellier (4 shared papers)Trever Grant Bivona (4 shared papers)Laurence Huc (2 shared papers)Anthony Lemarié (2 shared papers)Matthew A. Gubens (3 shared papers)
- Journals
- Cell Death and Differentiation (4 papers)Oncogene (3 papers)Cell Reports (2 papers)The EMBO Journal (2 papers)Journal of Cell Science (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Evangelos Pazarentzos
21 papers receiving 2.1k citations
Evangelos Pazarentzos's Hit Papers
Peers
Comparison fields: 5 of 97
- Cell Biology 522
- Cancer Research 314
- Oncology 496
- Molecular Biology 1.3k
- Pulmonary and Respiratory Medicine 371
Countries citing papers authored by Evangelos Pazarentzos
This map shows the geographic impact of Evangelos Pazarentzos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evangelos Pazarentzos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evangelos Pazarentzos more than expected).
Fields of papers citing papers by Evangelos Pazarentzos
This network shows the impact of papers produced by Evangelos Pazarentzos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evangelos Pazarentzos. The network helps show where Evangelos Pazarentzos may publish in the future.
Co-authors
The 25 scholars most cited alongside Evangelos Pazarentzos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies Hit paper breakdown → | 2015 | 462 |
| 2 | 2010 | 446 | |
| 3 | 2015 | 264 | |
| 4 | 2015 | 240 | |
| 5 | 2015 | 174 | |
| 6 | 2010 | 89 | |
| 7 | 2014 | 84 | |
| 8 | 2011 | 67 | |
| 9 | 2015 | 54 | |
| 10 | 2015 | 37 | |
| 11 | 2014 | 35 | |
| 12 | 2017 | 28 | |
| 13 | 2016 | 26 | |
| 14 | 2014 | 24 | |
| 15 | 2012 | 21 | |
| 16 | 2013 | 21 | |
| 17 | 2019 | 19 | |
| 18 | 2014 | 13 | |
| 19 | 2014 | 7 | |
| 20 | 2015 | 2 |
About Evangelos Pazarentzos
Evangelos Pazarentzos is a scholar working on Cancer Research, Molecular Biology, Immunology, Oncology and Cell Biology, having authored 21 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (5 papers), Mitochondrial Function and Pathology (5 papers), NF-κB Signaling Pathways (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), interferon and immune responses (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cell Biology (522 citations), Cancer Research (314 citations), Oncology (496 citations), Molecular Biology (1.3k citations) and Pulmonary and Respiratory Medicine (371 citations). Evangelos Pazarentzos has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Stefan Grimm, Christoph Datler, Ryota Iwasawa, Anne‐Laure Mahul‐Mellier, Trever Grant Bivona, Laurence Huc, Anthony Lemarié, Matthew A. Gubens, Victor R. Olivas and Nathan N. Alder. Their work appears in journals such as Cell Death and Differentiation, Oncogene, Cell Reports, The EMBO Journal and Journal of Cell Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.